2016

Pharmaceutical Company FCPA and Anti-Corruption Internal Investigation

Asia | Asia - China

FaegreBD led an internal investigation into activities of a pharmaceutical company's sales team, which triggered issues relating to the Foreign Corrupt Practices Act (FCPA) and PRC anti-corruption laws.

The Faegre Baker Daniels website uses cookies to make your browsing experience as useful as possible. In order to have the full site experience, keep cookies enabled on your web browser. By browsing our site with cookies enabled, you are agreeing to their use. Review Faegre Baker Daniels' cookies information for more details.